GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integrum AB (OSTO:INTEG B) » Definitions » Price-to-Free-Cash-Flow

Integrum AB (OSTO:INTEG B) Price-to-Free-Cash-Flow : N/A (As of Jun. 10, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Integrum AB Price-to-Free-Cash-Flow?

As of today (2024-06-10), Integrum AB's share price is kr54.80. Integrum AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 was kr-1.09. Hence, Integrum AB's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Integrum AB's Price-to-Free-Cash-Flow or its related term are showing as below:

OSTO:INTEG B's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 34.12
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Integrum AB's Free Cash Flow per Share for the three months ended in Jan. 2024 was kr-0.26. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was kr-1.09.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -18.30% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -1.00% per year.

During the past 9 years, Integrum AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 37.60% per year. The lowest was -200.10% per year. And the median was -14.30% per year.


Integrum AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for Integrum AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrum AB Price-to-Free-Cash-Flow Chart

Integrum AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only - - - - -

Integrum AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Integrum AB's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Integrum AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrum AB's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integrum AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Integrum AB's Price-to-Free-Cash-Flow falls into.



Integrum AB Price-to-Free-Cash-Flow Calculation

Integrum AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=54.80/-1.09
=N/A

Integrum AB's Share Price of today is kr54.80.
Integrum AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Integrum AB  (OSTO:INTEG B) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Integrum AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Integrum AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrum AB (OSTO:INTEG B) Business Description

Traded in Other Exchanges
Address
Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.

Integrum AB (OSTO:INTEG B) Headlines

No Headlines